ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

343 hedge funds and large institutions have $6.14B invested in Intra-Cellular Therapies Inc. in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 121 increasing their positions, 126 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
343
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$314M
Puts
$96.1M
Net Calls
Net Calls Change

Top Buyers

1 +$65.6M
2 +$47M
3 +$23.7M
4
Citadel Advisors
Citadel Advisors
Florida
+$22.5M
5
Ameriprise
Ameriprise
Minnesota
+$21.3M

Top Sellers

1 -$107M
2 -$66.5M
3 -$35.6M
4
DTC
Deep Track Capital
Connecticut
-$34.6M
5
Holocene Advisors
Holocene Advisors
New York
-$24.4M
Name Holding Trade Value Shares
Change
Change in
Stake
226
$344K
227
$341K
228
$337K
229
$325K
230
$320K
231
$318K
232
$318K
233
$317K
234
$313K
235
$313K
236
$304K
237
$303K
238
$298K
239
$293K
240
$287K
241
$283K
242
$277K
243
$272K
244
$271K
245
$261K
246
$259K
247
$258K
248
$256K
249
$254K
250
$253K